Joel Ackerman, Chief Executive Officer at CHAMPIONS ONCOLOGY, INC. (CSBR), bought 10,702 shares at $1.61 ($17K) on 2016-10-06, disclosed to the SEC on 2016-10-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.61 | 1,000 | $2K | 9.3% |
| 2 | $1.61 | 1,500 | $2K | 13.9% |
| 3 | $1.61 | 1,000 | $2K | 9.3% |
| 4 | $1.61 | 1,500 | $2K | 13.9% |
| 5 | $1.62 | 702 | $1K | 6.5% |
| 6 | $1.64 | 5,000 |
| $8K |
| 47.1% |
| Total | $1.63 avg | 10,702 | $17K | 100% |
| Filing → |
| DVA | SELL | 2021-08-06 | $9.9M | — | Filing → |
| CSBR | SELL | 2018-10-03 | $767K | — | Filing → |
| CSBR | BUY | 2016-10-20 | $5K | — | Filing → |